Vous êtes ici

Traitement des stades III

  • Which is the Better Prognostic Factor for Resected Non-small Cell Lung Cancer The Number of Metastatic Lymph Nodes or the Currently UsedNodal Stage Classification?

    3
    Revue: Journal of Clinical Oncology
  • Multimodality approach to mediastinal staging in non-small cell lung cancer. Faults and benefits of PET-CT: a randomised trial.

    2.01
    Revue: Thorax
  • Oral vinorelbine and cisplatin with concurrent radiotherapy after induction chemotherapy with cisplatin and docetaxel for patients with locally advanced non-small cell lung cancer: the GFPC 05-03 study.

    1.02
    Revue: Annals of Oncology

Pages